Bought 30 shares of Johnson & Johnson (JNJ) for $62.95 per share.
About the company:
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. Johnson & Johnson has more than 250 operating companies. The Company operates in three segments. The Consumer segment includes a range of products used in the baby care, skin care, oral care, wound care and women’s healthcare fields, as well as nutritional and over-the-counter pharmaceutical products. The Pharmaceutical segment includes products in the therapeutic areas, such as anti-infective, antipsychotic, cardiovascular, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, urology and virology. The Medical Devices and Diagnostics segment includes a range of products distributed to wholesalers, hospitals and retailers. In July 2009, Johnson & Johnson completed the acquisition of Cougar Biotechnology, Inc. with approximately 95.9% interest in Cougar Biotechnology’s outstanding common stock.
Related posts:
- Bought Berkshire Hathaway (BRK.B) Bought 20 shares of Berkshire Hathaway (BRK.B) for $71.02 per share. About the company: Berkshire Hathaway Inc. is a holding company owning subsidiaries that engage in a...
- Bought CanWel Building Materials Income Fund Bought 340 shares of CanWel Building Materials Income Fund (CWX-UN.TO) for $2.60 per share. About the company: CanWel Building Materials Income Fund (the Fund) is...
